Loading…

A spatial vaccination strategy to reduce the risk of vaccine-resistant variants

The COVID-19 pandemic demonstrated that the process of global vaccination against a novel virus can be a prolonged one. Social distancing measures, that are initially adopted to control the pandemic, are gradually relaxed as vaccination progresses and population immunity increases. The result is a p...

Full description

Saved in:
Bibliographic Details
Published in:PLoS computational biology 2022-08, Vol.18 (8), p.e1010391-e1010391
Main Authors: Zhang, Xiyun, Lobinska, Gabriela, Feldman, Michal, Dekel, Eddie, Nowak, Martin A, Pilpel, Yitzhak, Pauzner, Yonatan, Barzel, Baruch, Pauzner, Ady
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic demonstrated that the process of global vaccination against a novel virus can be a prolonged one. Social distancing measures, that are initially adopted to control the pandemic, are gradually relaxed as vaccination progresses and population immunity increases. The result is a prolonged period of high disease prevalence combined with a fitness advantage for vaccine-resistant variants, which together lead to a considerably increased probability for vaccine escape. A spatial vaccination strategy is proposed that has the potential to dramatically reduce this risk. Rather than dispersing the vaccination effort evenly throughout a country, distinct geographic regions of the country are sequentially vaccinated, quickly bringing each to effective herd immunity. Regions with high vaccination rates will then have low infection rates and vice versa. Since people primarily interact within their own region, spatial vaccination reduces the number of encounters between infected individuals (the source of mutations) and vaccinated individuals (who facilitate the spread of vaccine-resistant strains). Thus, spatial vaccination may help mitigate the global risk of vaccine-resistant variants.
ISSN:1553-7358
1553-734X
1553-7358
DOI:10.1371/journal.pcbi.1010391